ISSN:
1569-8041
Keywords:
high-dose chemotherapy
;
Hodgkin's disease
;
radiation therapy
;
salvage therapy
Source:
Springer Online Journal Archives 1860-2000
Topics:
Medicine
Notes:
Abstract The expected event-free survival for patients undergoing high-dose salvage therapy for Hodgkin's disease is 40%-60%. Three-quarters of these patients will relapse in prior sites of disease. Radiation therapy is a very effective local-regional modality in Hodgkin's disease. It is possible that the judicious use of radiation can improve the event-free survival of high-dose salvage programs. Retrospective analysis supports this concept, but the rationale should be incorporated and tested in prospective clinical trials.
Type of Medium:
Electronic Resource
URL:
http://dx.doi.org/10.1023/A:1008423920793